Powerful Medical Receives €40 Million IPCEI Grant — read the full story

Powerful Medical
23. December 2023
5 min to read

Validation of an Automated Artificial Intelligence System for 12‑lead ECG Interpretation

Overview:

Trained on over 1 million ECGs, the PMcardio Core AI ECG Model was evaluated across six diagnostic categories, outperforming primary care physicians by up to 73% and matching cardiologists in overall accuracy. Additionally, it demonstrated clear superiority over traditional ECG machine-generated diagnoses, which are limited by rule-based algorithms, restricted pattern recognition, and an inability to incorporate clinical context.

Published In: Journal of Electrocardiology
Presented Date: December 23, 2023

Highlights:

  • AI-powered system detects 20 essential diagnostic patterns and standard ECG measurements from 12-lead ECGs.
  • AI outperforms state-of-the-art CIE for 13 of 20 evaluated diagnostic patterns and is non-inferior for the remaining.
  • AI system has the potential to reduce burden on cardiologists and improve timely and efficient referral.

Background

The electrocardiogram (ECG) is one of the most accessible and comprehensive diagnostic tools used to assess cardiac patients at the first point of contact. Despite advances in computerized interpretation of the electrocardiogram (CIE), its accuracy remains inferior to physicians. This study evaluated the diagnostic performance of an artificial intelligence (AI)-powered ECG system and compared its performance to current state-of-the-art CIE.

Methods

An AI-powered system consisting of 6 deep neural networks (DNN) was trained on standard 12‑lead ECGs to detect 20 essential diagnostic patterns (grouped into 6 categories: rhythm, acute coronary syndrome (ACS), conduction abnormalities, ectopy, chamber enlargement and axis).

An independent test set of ECGs with diagnostic consensus of two expert cardiologists was used as a reference standard. AI system performance was compared to current state-of-the-art CIE. The key metrics used to compare performances were sensitivity, specificity, positive predictive value (PPV), negative predictive value (NPV), and F1 score.

Results

A total of 932,711 standard 12‑lead ECGs from 173,949 patients were used for AI system development. The independent test set pooled 11,932 annotated ECG labels. In all 6 diagnostic categories, the DNNs achieved high F1 scores: Rhythm 0.957, ACS 0.925, Conduction abnormalities 0.893, Ectopy 0.966, Chamber enlargement 0.972, and Axis 0.897. The diagnostic performance of DNNs surpassed state-of-the-art CIE for the 13 out of 20 essential diagnostic patterns and was non-inferior for the remaining individual diagnoses.

Conclusion

Our results demonstrate the AI-powered ECG model’s ability to accurately identify electrocardiographic abnormalities from the 12‑lead ECG, highlighting its potential as a clinical tool for healthcare professionals.


Authors: Robert Herman, MD, Anthony Demolder, MD, PhD, Boris Vavrik, MSc, Michal Martonak, MSc, Viera Kresnakova, MSc, PhD, Andrej Iring, MSc, Timotej Palus, Ing, Jakub Bahyl, MSc, Olivier Nelis, MSc, Monika Beles, RN, Davide Fabbricatore, MD, Leor Perl, MD, Jozef Bartunek, MD, PhD, Robert Hatala, MD, PhD

Author-Logo_PM
Powerful Medical leads one of the most important shifts in modern medicine by augmenting human-made clinical decisions with artificial intelligence. Our primary focus is on cardiovascular diseases, the world’s leading cause of death.

About PMcardio

PMcardio is a CE-certified AI that reads ECGs and offers a complex assessment of 49 cardiac conditions. Clinically validated in 15+ studies and trusted by over 100,000 clinicians, it delivers rapid, expert‑level interpretations, empowering emergency physicians, GPs, nurses, paramedics, and cardiologists to act with confidence at the point of care. Available for Individuals and Organizations.

About Powerful Medical

Established in 2017, Powerful Medical has embarked on a mission to revolutionize the diagnosis and treatment of cardiovascular diseases. We are a medical company backed by 28 world-class cardiologists and led by our expert Scientific Board with decades of experience in daily patient care, clinical research, and medical devices. The results of our research are implemented, developed, certified, and brought to market by our 50+ strong interdisciplinary team of physicians, data scientists, AI experts, software engineers, regulatory specialists, and commercial teams.

Share this article

Relevant Publications

Artificial intelligence-enhanced ECG detection of acute coronary occlusion in chest pain patients with ST-elevation in lead aVR – A direct comparison to conventional ECG criteria

In a single‑centre retrospective study of 145 consecutive emergency‑department patients whose first ECG showed ≥1 mm ST‑elevation in lead aVR, investigators compared conventional electrocardiographic rules with a deep‑learning classifier (PMcardio “Queen of Hearts”) for recognising an acute coronary occlusion (ACO). Angiography and biomarker adjudication proved ACO in 19 patients (13 %). At an optimised probability threshold, the AI system achieved an area‑under‑the‑ROC curve of 0.918, detected 63 % of occlusions, and—crucially—generated no false‑positive calls in the 54‑patient rule‑out subgroup. By contrast, classic STEMI millimetre criteria identified only one in four occlusions and would have prompted between four and fourteen unnecessary emergency catheterisations.

AI-enhanced recognition of occlusions in acute coronary syndrome (AERO-ACS): a retrospective study

In a one‑year, single‑centre cohort of 217 cath‑lab patients (72 STEMI, 145 NSTEMI), the AERO‑ACS study tested PMcardio’s AI ECG against traditional ST‑elevation rules for detecting angiographic occlusion‑MI. The algorithm matched STEMI sensitivity (86.5 % vs 83.3 %) while raising specificity to 82.2 % (vs 66.0 %), achieved 100 % sensitivity in STEMI cases, and flagged occlusions linked to a 12‑fold higher in‑hospital mortality risk—suggesting more accurate triage with fewer unnecessary activations.

Join over 100,000 healthcare professionals who are already taking advantage of AI